Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 4 of the 13 calendar months from Oct 2025 to Oct 2026: Dec 2025, May 2026, Jun 2026 and Jul 2026.
- Largest single sale: $761K (5,000 shares) of Neurocrine Biosciences Inc on Dec 15, 2025. Filing
- Last sale before this period: May 17, 2024.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Neurocrine Biosciences Inc (NBIX) | Director | Sep 12, 2019 | Jul 30, 2026 |
| CVS Health (CVS) | Director | Nov 25, 2024 | May 15, 2026 |
| Centene Corporation (CNC) | Former Director | Jan 18, 2022 | Apr 4, 2022 |
Also a director at
CVS Health (CVS), Centene Corporation (CNC) (no filing in the last 18 months)
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jul 29, 2026, Neurocrine Biosciences Inc: 842 shares acquired by exercising options. 1 filing: 1
- Jul 28, 2026, Neurocrine Biosciences Inc: sold 1,250 shares for $228K, under a disclosed plan. 1 filing: 1
- Jun 4, 2026, Neurocrine Biosciences Inc: sold 1,250 shares for $210K, under a disclosed plan. 1 filing: 1
- May 21, 2026, Neurocrine Biosciences Inc: 1,659 shares vested. 1 filing: 1
- May 14, 2026, CVS Health: 1,447 shares awarded. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.